Cellebrite (CLBT) names Shiven Ramji CEO as Q2 results cut 2026 ARR/revenue outlook but raise EBITDA target; shares drop 28% premarket.
$CLBT
Price history, market instrument context, member research, and related headlines in one place.
CLBT key statistics
NasdaqGSUSD
52-week range
$9.5812%$19.98
Latest session $10.68–$11.43Cellebrite DI Ltd. (CLBT) is a stock instrument quoted on NasdaqGS in USD. The most recently published price is $10.83, down $0.55 (4.83%) from the previous close of $11.38. It has traded between $10.68 and $11.43 in the latest session. Over the past year it has ranged from $9.58 to $19.98, leaving it in the lower quarter of its 52-week range (12%). Reported volume for the session was 2M. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Cellebrite Q2 2026 Earnings Preview — See source for full details.
Loading $CLBT research…